![Ross Breckenridge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ross Breckenridge
Vorstandsvorsitzender bei Arjuna Therapeutics
Aktive Positionen von Ross Breckenridge
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CdLS Foundation UK & Ireland | Direktor/Vorstandsmitglied | - | - |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - |
Karriereverlauf von Ross Breckenridge
Ehemalige bekannte Positionen von Ross Breckenridge
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REVA MEDICAL INC | Direktor/Vorstandsmitglied | 28.01.2015 | 01.01.2020 |
Independent Dir/Board Member | 28.01.2015 | 01.01.2020 | |
Silver Creek Pharmaceuticals, Inc.
![]() Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 16.09.2015 | 01.09.2018 |
Vorstandsvorsitzender | 16.09.2015 | 01.09.2018 | |
Präsident | 16.09.2015 | 01.09.2018 | |
EMPOWER INDIA LIMITED | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Ross Breckenridge
University of Oxford | Doctorate Degree |
University of Cambridge | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 4 |
Australien | 2 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 5 |
Doctorate Degree | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EMPOWER INDIA LIMITED | Distribution Services |
Private Unternehmen | 4 |
---|---|
REVA Medical, Inc.
![]() REVA Medical, Inc. Medical SpecialtiesHealth Technology REVA Medical, Inc. engages in the development and commercialization of medical devices. It focuses on polymer-based bioresorbable products for vascular applications. The company was founded by Robert Bernard Stockman on June 3, 1998 and is headquartered in San Diego, CA. | Health Technology |
Silver Creek Pharmaceuticals, Inc.
![]() Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
CdLS Foundation UK & Ireland | Miscellaneous |
Arjuna Therapeutics
![]() Arjuna Therapeutics Medical/Nursing ServicesHealth Services Arjuna Therapeutics is a Spanish biotechnology company that specializes in developing a new class of small molecules called therapeutic molecular clusters (TMCs) for the treatment of cancer. Arjuna Therapeutics is based in A Coruña, Spain. TMCs are biomarker-driven and selectively kill cancer cells that exhibit high levels of ROS. The company believes that their approach to treating life-threatening diseases without effective treatment options will accelerate FDA approval. The company was founded by Fernando Dominguez and Arturo López Quintela, and the CEO is Ross Breckenridge. | Health Services |
- Börse
- Insiders
- Ross Breckenridge
- Erfahrung